Your browser doesn't support javascript.
loading
Guillain-Barré syndrome in France: a nationwide epidemiological analysis based on hospital discharge data (2008-2013).
Delannoy, Alexandra; Rudant, Jérémie; Chaignot, Christophe; Bolgert, Francis; Mikaeloff, Yann; Weill, Alain.
  • Delannoy A; Direction de la stratégie, des études et des statistiques, French National Health Insurance (Caisse Nationale d'Assurance Maladie des Travailleurs Salariés), Paris, France.
  • Rudant J; Direction de la stratégie, des études et des statistiques, French National Health Insurance (Caisse Nationale d'Assurance Maladie des Travailleurs Salariés), Paris, France.
  • Chaignot C; Direction de la stratégie, des études et des statistiques, French National Health Insurance (Caisse Nationale d'Assurance Maladie des Travailleurs Salariés), Paris, France.
  • Bolgert F; Réanimation Neurologique, Neurologie 1, AP-HP, Hôpital Pitié-Salpêtrière, Paris, France.
  • Mikaeloff Y; Université Paris-Saclay, Université Paris-Sud, CESP, INSERM, Villejuif, France.
  • Weill A; Unité de Rééducation Neurologique Infantile (URNI), AP-HP, Hôpital Bicêtre, Bicêtre, France.
J Peripher Nerv Syst ; 22(1): 51-58, 2017 03.
Article en En | MEDLINE | ID: mdl-27991707
Guillain-Barré syndrome (GBS) is potentially life threatening and typically occurs after an infection. No detailed information is available concerning the epidemiological characteristics of GBS in France. We estimated age- and sex-specific incidence rates (IRs) based on a French nationwide hospital discharge database. All patients hospitalized for GBS between 2008 and 2013 were identified by International Classification of Diseases-10 code G61.0 as principal diagnosis. Patients previously hospitalized for GBS in 2006 and 2007 were excluded. Sensitivity analyses were performed by considering alternative case definitions, based on more restrictive sets of codes. A total of 9,391 patients were identified, leading to an overall crude IR of 2.42 per 100,000 person-years (world standardized IR = 2.00). IRs increased with age, reaching a peak in the 70-79-year age group. IR was 46% higher in men than in women, and 44% higher in winter than in summer. In children, the highest IR was observed at the age of 2 years. These patterns were not modified by the use of alternative case definitions. This French nationwide study showed similar GBS epidemiological patterns in adults to those reported in other countries. We also report a childhood incidence peak around the age of 2 years, as previously observed in Latin American and Chinese populations.
Asunto(s)
Palabras clave

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Alta del Paciente / Síndrome de Guillain-Barré Tipo de estudio: Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adolescent / Adult / Aged / Aged80 / Child / Child, preschool / Female / Humans / Infant / Male País como asunto: Europa Idioma: En Año: 2017 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Alta del Paciente / Síndrome de Guillain-Barré Tipo de estudio: Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adolescent / Adult / Aged / Aged80 / Child / Child, preschool / Female / Humans / Infant / Male País como asunto: Europa Idioma: En Año: 2017 Tipo del documento: Article